Alternatives to Omzo

Injection or sublingual, both molecules — but we list it only with full disclosure: a 2025 FDA warning letter and a BBB complaint pattern around surprise 3-month charges make cancellation the real risk here.

• $2 less per month on average than Omzo
• has an oral option if you would rather not inject
• scores 70/100 against Omzo's 50

Semaglutide: $297/mo; tirzepatide: Oral: $891 prepaid for a listed 3-month supply; injection price unconfirmed. The oral tirzepatide section lists a three-month supply at $891 paid in full, but its delivery text conflicts on duration; injectable tirzepatide pricing needs confirmation.

• $2 less per month on average than Omzo
• scores 81/100 against Omzo's 50

A compounded program that advertises ongoing provider care, metabolic testing every six months and shipping within its price. Semaglutide is $249 and tirzepatide $329 every four weeks without a longer commitment; lower equivalents require 12-, 24- or 48-week terms. Microdose and combination options need separate current quotes.

• $29.25 less per month on average than Omzo
• scores 81/100 against Omzo's 50

The widest menu on our list — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, prices published for every plan length, and cancellation terms among the most restrictive we have read.

• $100 less per month on average than Omzo
• has an oral option if you would rather not inject
• scores 76/100 against Omzo's 50

The most complete set of routes on our list — a real branded lane through insurance or LillyDirect, a compounded lane priced the same at every dose, and a non-GLP-1 generics lane — undercut by a three-day refund window and a complaint pattern that sits squarely on billing.

• has an oral option if you would rather not inject
• scores 74/100 against Omzo's 50

Semaglutide: $199/mo; tirzepatide: Starting at $399/mo. Oral semaglutide starts at $299 and oral tirzepatide at $399; confirm your dose, plan length and cancellation terms.

• $100 less per month on average than Omzo
• has an oral option if you would rather not inject
• scores 78/100 against Omzo's 50

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the typical price we track, and the oral capsules cost the same or more than the injections.

• $50 less per month on average than Omzo
• has an oral option if you would rather not inject
• scores 57/100 against Omzo's 50

A women's health brand many mothers already use for birth control or UTIs, now offering GLP-1 care. Its only compounded option is semaglutide drops held under the tongue, $225 for a 28-day bottle, so there is no needle and no compounded tirzepatide. Wisp's own fine print says the drop formula has only been tested on lab tissue, not in people. Brand Wegovy and Zepbound are available for a $99 monthly consult, with the pen bought at your pharmacy, where insurance can help. Drops reach 27 states and DC, and a medical director is named.

• $55.25 less per month on average than Omzo
• has an oral option if you would rather not inject
• scores 56/100 against Omzo's 50

Every price on the front page of this Spanish-language practice ends in the same three words: con plan anual. The $179 a month it advertises for injectable semaglutide is $2,148 paid up front; month to month the same treatment is $269. What makes it worth reading anyway is that the pricing page publishes both, and that every savings figure on it survives recomputation — on our list, a discount badge whose arithmetic is honest is the exception rather than the rule.

• $30 less per month on average than Omzo
• has an oral option if you would rather not inject